Clinical trials
Completed Primary Myelofibrosis trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 5 |
| Wake Forest University Health Sciences | 3 |
| City of Hope Medical Center | 2 |
| Roswell Park Cancer Institute | 2 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Case Comprehensive Cancer Center | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Martin, Paul | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Massachusetts General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 29 |
| Myeloproliferative Disorders | 27 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 25 |
| Hodgkin Disease | 23 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 23 |
| Lymphoma, Non-Hodgkin | 23 |
| Multiple Myeloma | 23 |
| Leukemia, Myeloid, Acute | 22 |
| Burkitt Lymphoma | 21 |
| Lymphoma, Large B-Cell, Diffuse | 21 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.